Figure 5.
Figure 5. AG1296, PKC412, and SU5614 inhibit FLT3-mediated STAT5 phosphorylation. Mutant FLT3-expressing Ba/F3 cells were incubated with the indicated concentrations of (A) AG1296, (B) PKC412, and (C) SU5614 or vehicle alone for 4 hours prior to cell lysis. Parental Ba/F3 cells were treated likewise but in the presence of IL-3. Activation of STAT5 was demonstrated by immunoblotting the total cell lysates with anti-pSTAT5 antibody (upper panel). After stripping the membrane was reprobed with total anti-STAT5 antibody (lower panel). Optical density (OD) ratios of STAT5 phosphorylation of treated versus untreated cells are shown below the upper panel.

AG1296, PKC412, and SU5614 inhibit FLT3-mediated STAT5 phosphorylation. Mutant FLT3-expressing Ba/F3 cells were incubated with the indicated concentrations of (A) AG1296, (B) PKC412, and (C) SU5614 or vehicle alone for 4 hours prior to cell lysis. Parental Ba/F3 cells were treated likewise but in the presence of IL-3. Activation of STAT5 was demonstrated by immunoblotting the total cell lysates with anti-pSTAT5 antibody (upper panel). After stripping the membrane was reprobed with total anti-STAT5 antibody (lower panel). Optical density (OD) ratios of STAT5 phosphorylation of treated versus untreated cells are shown below the upper panel.

Close Modal

or Create an Account

Close Modal
Close Modal